CBDOilReviews.com

Category: Legal & Regulation

  • A Dozen Marijuana Proposals Filed By New York City Council Members In Just One Day

    A Dozen Marijuana Proposals Filed By New York City Council Members In Just One Day

    New York may be closer to legalizing a commercial marijuana market. This week, ten resolutions and two bills were filed by council members. One resolution proposed that legislators pass and the governor sign a bill providing cannabis licensing a priority for those who have been harmed by the drug war. Another resolution demanded that legislation remedy “disparate burdens placed on people of color in the enforcement of marijuana prohibition.”

    Council Member Daneek Miller introduced another resolution for federal cannabis reform in the form of a Marijuana Justice Act. This proposed bill would put a stop to federal marijuana prohibition. Further, states would not be penalized where cannabis enforcement is executed unfairly.

    Council member Jumaane Williams also introduced a proposal that would prohibit state employees from performing a pre-employment drug test concerning cannabis – making it easier for those with cannabis-related offenses to find jobs. Williams stated in a press release, “We need to be creating access points for employment, not less – and as we move toward legalization, it makes absolutely no sense that we’re keeping people from finding jobs or advancing their careers because of marijuana use.”

    There were several resolutions about technical matters as well. For example, one proposed reclassifying THC and other “marijuana-based products” as “equivalent of flower marijuana.”

    Further, there were four council members that signed a resolution concerning the New York City Administration for Children’s Services in that the administration would need to implement a policy stipulating that consumption or possession of cannabis “does not by itself create an imminent risk of harm to the child, warranting the child’s removal.”

  • First Ever Congress Hearing On Cannabis Banking Entities And Marijuana Business Concerns

    First Ever Congress Hearing On Cannabis Banking Entities And Marijuana Business Concerns

    The 116th Congress spent Wednesday holding a hearing concerning the banking industry and marijuana. During the hearing a financial subcommittee questioned witnesses concerning banking access can improve public safety, the cash-only basis quality and transparency, and whether the cash has the odor of marijuana.

    Gregory Meeks (D-NY), the subcommittee’s chair, state,

    “The absence of broader, permanent regulatory framework continues to keep nearly all banks out of this growing industry despite a clear interest. Today’s hearing will allow us to being consideration of draft legislation to bring transparency, accountability and address major drivers of violent crime in this space.”

    The hearing did not seem pro marijuana. Before the hearing, several lawmakers circulated a draft bill that would protect banks from penalization by federal financial regulators in the event that the banks received profits from cannabis-related transactions. Under the draft bills, such transactions “shall not be considered as proceeds from unlawful activity.”

    According to Rep. Denny Heck (D-WA),

    “Today, after six years, we finally have a hearing, and it comes too late. Too late to prevent dozens of armed robberies in my home state of Washington. Too late for Travis Mason… a 24-year-old Marine veteran in Aurora, Colorado, who reported for work as a security guard and Green Heart Dispensary on June 18, 2016 and was shot dead that night by an armed robber.”

    Further, “We have the power in this committee to prevent murders and armed robberies.” Hicks was referring to the position that preventing marijuana businesses from accessing banks would lead to operation on and all-cash basis, and that it may not be beneficial.

    Witnesses also appeared that the hearing, including California State Treasurer Fiona Ma, Law Enforcement Action Partnership (LEAP) Executive Director Major Neill Franklin, D.C.-based medical marijuana dispensary owners, the chair of Smart Approaches to Marijuana (an anti-legalization group), and banking representatives.

    In written testimony, Ma stated,

    “The Committee is undoubtedly aware that cannabis businesses are not alone in struggling to gain access to banking—even though theirs is the most difficult situation. Any business that handles significant amounts of currency is also subject to greater scrutiny by the financial services industry for all of the reasons that are well understood by members of this committee.”

    Further,

    “an effective safe harbor mechanism in federal law promotes the safety of the public, improves the efficiency of collecting the taxes and fees we use to regulate the industry, and does not allow the banks and credit unions to totally abdicate their responsibilities to know their customers and avoid illicit money laundering.”

    A retired Maryland police office named Franklin also testified and stated that current laws,

    “encourage tax fraud, add expensive monitoring and booking expenses and – most importantly – leave legitimate businesses vulnerable to theft, robbery and the violence that accompany those crimes. I’m not one for fear mongering – what I testify to here today is rooted in experience and research. Any police officer who has worked the street, or investigated enough robberies, will testify to the same regarding any business forced to handle large amounts of cash.”

    The question of whether providing marijuana business owners access to banks would be “compounding the racial wealth gap right now,” arose from Ocasio-Cortez. Corey Barnette, a marijuana business owner from DC stated that he does not think that the marijuana business, as it exists today, is reflect of society as a whole. But, he also argued that banking access would mean that the tools to open a marijuana business is “within reach” with banking access.

    One of the cosponsors of the banking bill, Heck, stated the driving forces behind his advocacy for legislation improving access to financial services for the marijuana industry. His main driving force was his brother, who died after exposure to herbicides after serving in Vietnam.

    Heck stated, “Toward the end of his life, the only relief he could find was from the illegal consumption of marijuana,”

    Heck said.

    “I’ve always thought and lived with the irony that the same nation that asked my brother to put on a uniform and put his life at risk—in an activity that eventually did in fact take his life—held him to be criminal when he found the relief in the only way he could.”

    Aaron Smith, executive director of the National Cannabis Industry Associated later released a press release,

    “Congress has an opportunity to make a simple policy change that will greatly benefit communities and small businesses by approving cannabis banking reform,”

    Aaron Smith, executive director of the National Cannabis Industry Association, said in a press release,

    “Representatives Perlmutter and Heck should be commended for pushing for this hearing so that this issue can get the attention it deserves and we can move toward a sensible policy that will increase public safety and transparency in this burgeoning industry.”

    Representative Earn Blumenauer (D-OR) also issued a blueprint concerning the legislative path to marijuana legislation and a press release concerning the access to banking issue. Therein, he noted that the access issue is “one of the first dominos that should fall.” He added that the hearing indicates that Congress is “finally making progress toward addressing the irrational, unfair, and unsafe denial of regular banking services for state-legal marijuana businesses around the country.”

    Another cosponsor of the bill, Perlmutter, stated,

    “Today’s hearing was a big deal for the thousands of employees, businesses and communities across this country who have been put at risk because they have been forced to deal in piles of cash while Congress sticks its head in the sand.”

    He added,

    “The American voters have spoken and continue to speak, and the fact is you can’t put the genie back in the bottle. The SAFE Banking Act is focused solely on taking cash off the streets and making our communities safer, and only Congress can take these steps to provide this certainty for businesses and financial institutions across the country.”

    Heck finally concluded the hearing stating,

    “We listened to hours of testimony today about the dangerous position we put store owners and employees in by forcing them to do all of their business in cash. We can fix this. We don’t have to force them to operate in a way that makes it difficult to secure and track their funds.”

    He added,

    “Regardless of our views of marijuana use, the voters have decided in states all over this country that they want recreational and medicinal markets. To continue to do nothing to protect public safety would be negligence.”

  • South Dakota Lawmakers Are Joining The Hemp Boom As Farming Cultivation Gets Landslide Vote

    South Dakota Lawmakers Are Joining The Hemp Boom As Farming Cultivation Gets Landslide Vote

    Lawmakers in South Dakota seem to in favor of hemp production, even though the state’s Governor is more interested in sidelining the proposal. This week, the South Dakota House voted 62 to 2 to allow hemp farming, even in light of Governor Kristi Noem’s request to shelve the proposal this session.

    In Noem’s view, the state is not prepared for hemp production due to the outstanding issues about enforcement, public safety, and taxpayer costs. North Dakota is already well on its way toward hemp production – the state reported 2,778 acres of hemp grown in 2018, which means it is one of the largest hemp producers in the country.

    Although the 2018 Farm Bill allows for hemp production through state pilot programs, it is not clear whether states can ban production. States that do not take any action on hemp may not be subject to oversight by the Department of Agriculture as well.

  • New ‘Temporary Cannabis Tax Reduction Bill’ Looks To Lower Taxes On California CBD Sales

    New ‘Temporary Cannabis Tax Reduction Bill’ Looks To Lower Taxes On California CBD Sales

    California may have legalized CBD, but that does not mean that it isn’t expensive. Interestingly enough, there is still a strong black market as well, perhaps due to the high prices. In an effort to thwart black market sales, a new bill has been introduced. The bill, called the Temporary Cannabis Tax Reduction Bill, proposed reducing state exercise taxes from 15% to 11% until 2022. In addition, cultivation taxes would be on the decline in the coming three years.

    The bill is supported by Fiona Ma, the state’s treasurer. According to Ma, “We don’t tax start-up businesses when they start. We need to do better.” Those who support the bill do so due to the high taxes and limited access to banking, two significant issues faced by CBD businesses. Currently, CBD businesses pay 45% in taxes. The high tax rate means that they need to increase their prices in order to make a profit. In turn, the black market is much more affordable.

    California is not the only state whose CBD businesses are struggling. Other states that have legalized CBD also have high tax rates. Moreover, another challenge is that the federal government still has not legalized CBD, making it a risky venture because it would be in violation of federal law.

    According to Rob Botana, who discussed the bill,

    “AB 286 is an important step to ensure that we protect legitimate taxpaying businesses and stop the illegal black market in California. The black market continues to undercut legal businesses that are complying with state regulations.”

    Further, Troy Dayton of Arcview Group stated,

    “The whole California system for adult-use legalization implementation has been a mess. California is the first state where the total retail sales went down after they transitioned to adult use because it’s so complex and the taxes are so high and everything else.”

  • European Commission Reclassifies CBD (Cannabidiol) Supplement Ingredient As Novel Food

    European Commission Reclassifies CBD (Cannabidiol) Supplement Ingredient As Novel Food

    Although awaiting an official ruling, the European Commission has considered to add the term “cannabinoids” to the Novel Foods catalog.

    The definition of the term would be,

    “. . . extracts of Cannabis sativa L. and derived products containing cannabinoids are considered novel foods as a history of consumption has not been demonstrated.”

    The catalog would also state,

    “This applies to both the extracts themselves and any products to which they are added as an ingredient (such as hemp seed oil). This also applies to extracts of other plants containing cannabinoids. Synthetically obtained cannabinoids are considered as novel.”

    It seems that other countries within the EU, including France, Germany, Italy, the Netherlands and the UK, are asking for the amended to the catalog. Further, the UK Food Standard’s Agency has pushed to remove the products from commercial sale while the change is pending.

    The change would impact the ability for producers to sell products for 18 months.

    The FSA stated,

    “We are considering the way forward in light of this clarification at EU level. We are meeting with relevant industry representative bodies, local authorities and other stakeholders to clarify how to achieve compliance in the marketplace in a proportionate manner.”

    The EFSA is expected to provide a final opinion by March 2019. The European Industrial Hemp Association has requested clarification from the European Commission.

    It also reiterated its position, stating,

    “Hemp extracts and tinctures were indeed made and sold in products, which would nowadays be ‘supplements’ up to 80 years ago.”

    The associated added,

    “Other evidence shows the use of hemp green parts (flowers, leaves) in applications such as ‘hemp-beer’ brewing and herbal infusions/tea making. Hemp flower used for production of beer-like beverages have been recognized as food ingredients by the European commission since 1998.”

    The World Health Organization recently published a report in the summer of 2018. The report determined that CBD has a good safety profile, generally.

    According to Dr. Sarah Brewer,

    “Given that there is some uncertainty on the future free availability of CBD supplement, I’d recommend that people who find it beneficial for well-being continue as previously by ordering from a trusted supplier and continuing to take their CBD Oil.”

  • Will The World Health Organization (W.H.O.) Reclassify Cannabis?

    Will The World Health Organization (W.H.O.) Reclassify Cannabis?

    On February 1, 2019, the World Health Organization announced that cannabis should be reclassified under international drug treaties. The proposed reclassification would remove cannabis and its resin from the definition of a Schedule IV drug under the Single Convention on Narcotic Drugs of 1961.

    If accepted, the reclassification would prevent countries relying on international treaties to ban marijuana. Rather, they would just need to ban it under their own laws. The Americans for Safe Access posits that cannabis and the resin were categorized as a Schedule IV substance to motivate western countries to ban the substance.

    According to Steph Sherer, the founder and president of Americans for Safe Access,

    “We are extremely pleased that the World Health Organization has finally recognized the therapeutic potential of cannabis and its derivatives as a safe and effective medicine. With an international rescheduling or de-scheduling of cannabis, the U.S. government can no longer use the excuse that cannabis has no medical value.”

    Further, Dr. Ethan Russo, the director of the International cannabis and Cannabinoids Institute added,

    “It is gratifying that the World Health Organization has recognized the scientific fact that cannabis and its derivatives have demonstrable therapeutic properties and can be the base for safe and effective medicines. It is now incumbent upon governments of the USA and other nations to eliminate the barriers to research on cannabis and allow its free commerce across state lines and international frontiers.”

    In addition to focusing on cannabis, the WHO also recommended that THC and its isomers be removed from the definition of Schedule II banned substances under the 1971 Convention on Psychotropic Substances and rather, be added as a Schedule I substance under the Single Convention of 1961.

    As for cannabidiol, the WHO reported that,

    “pure cannabidiol (CBD) should not be scheduled within the International Drug Control Conventions by adding a footnote to the entry for cannabis and cannabis resin in Schedule I of the Single Convention on Narcotic Drugs (1961) to read “Preparations containing predominately cannabidiol and not more than 0.2 percent of delta-9-tetrahydrocannabinol are not under international control.”

    The proposal will be brought before the UN commission on Narcotics Drugs in March. The member nations will then vote to either accept or reject the proposal. Chances are, states that have already legalized cannabis will be in favor of the change. There is no telling how the United States will vote.

  • Arizona Supreme Court to Rule on Whether or Not if Hashish is Medical Marijuana?

    Arizona Supreme Court to Rule on Whether or Not if Hashish is Medical Marijuana?

    A new issue has made its way to the Arizona Supreme Court – the question is whether cannabis extracts are legal under the state’s medical marijuana a program. The issue made its way to the state’s Supreme Court from a 2016 conviction.

    In 2016, Rodney Jones of Yavapai County was convicted of possession of hashish, even though he had a medical marijuana license. He appealed the conviction, and the court affirmed. Thereafter, Jones filed a petition for review to the Arizona Supreme Court and a number of advocates, in support of Jones, filed their own amicus briefs.

    Interestingly enough, the issue has also turned into a political one. Arizona’s Attorney General, Mark Brnovich, did not take a stance against the petition for review – but merely implored the court to provide clarification. However, Yavapai County Attorney Sheila Polk did file a petition in opposition.

    By accepting the petition for review, the state’s highest court has put into question whether dispensaries, and the sale or possession of shatter, edibles, cartridges, and vapes, is legal. The question upon review is not a new one and it is not without its own controversy. Since voters approved making concentrates legal in 2010, there has been debate as to whether resin extracts, which is the part of the plant that hashish is made out of and thus falls under, are legal.

    The law identifies “any preparation or mixture” of the cannabis plant as legal medical marijuana. However, resin is defined separately and is identified as a “narcotic.” Those who possess the resin face stricter penalties for possession.

  • California Cannabis: Examining the CDPH Permanent Regulations

    California Cannabis: Examining the CDPH Permanent Regulations

    Permanent cannabis regulations were recently adopted by California. Each agency has its own permanent rules. The changes concern the California Department of Public Health Manufactured Cannabis Safety Branch (“CDPH-MCSB”) regulations. Here is an overview of what the main changes seem to be:

    Cannabis Safety Regulations

    Eliminating Farm Bill Hemp-CBD Ingredients and Additives

    California’s Department of Health Food and Drug Brand (FDB) issued a series of frequently asked questions. One of the questions that arose is whether the FDB prohibits hemp-CBD in human and pet “food.” The FDB responded in the affirmative and as a result, the CDPH-MCSB has done so as well. The new regulation, 40175(c) provides, “a manufacturer licensee shall only use cannabinoid concentrates and extracts that are manufactured or processed from cannabis obtained from a licensed cannabis cultivator.” Essentially, Farm Bill hemp-CBD ingredients or additives are prohibited, unless it is derived from a licensed cannabis cultivator. Otherwise, Farm Bill protections will not apply.

    Owners and Interest Holders

    Financial interest owners and entity owners have come under scrutiny by the state – that is, the state prefers to vet them before they open shop. The Bureau of Cannabis Control (“BCC”) also has its own rules concerning how the process works. As for the MCBS, the regulations state “if the owner . . . is an entity, then the chief executive officer and members of the board of directors or the entity shall be considered owners.” And financial interest holders “shall be disclosed on the application for licensure.” The BCC’s rules seem to be much stricter for owners and financial interest holders.

    Changes in Ownership

    Unlike the BCC, the MSBC may be much easier on those who are looking to chance licensee ownership. While the BCC requires that if all owners are being bought-out, the entity cannot operate until the change in ownership is reviewed and verified by the BCC. Dissimilarly, the MCSB does not have such a requirement under the new regs. Rather, the regulations state:

    “The licensee shall notify the [MCSB] of the addition or removal of an owner through [the agency’s online system] within 10 calendar days of the change; Any new owner shall submit the information required [by law]; The [MCSB] shall review the qualifications of the new owner in accordance with [state law] and these regulations to determine whether the change would constitute grounds for denial of the license. The [MCSB] may approve the addition of the owner, deny the addition of the owner, or condition the license as appropriate, to be determined on a case-by-case basis; An owner shall notify the [MCSB] through [the state agency’s online system] of any change in their owner information . . . within 10 calendar days of the change; and a licensee shall notify the [MCSB] through [the state’s online system] of any change in the list of financial interest holders . . . within 10 calendar days of the change.”

    Labeling

    Labeling is not as friendly as other areas under the MSBC. Rather, it is still comprehensive. Manufacturers must ensure that edible cannabis products, concentrates, and topical cannabis products have outer packaging with all of the necessary information for a primary panel. As for inhaled products, they must feature a symbol representing a black triangle, cannabis leaf, and “!” and “CA” beneath. The specific labeling requirements also apply to pre-roll and packaged flowers. The additional technical requirements also include other features, such as the product’s weight in both U.S. units and metric.

    Packaging

    Retailers must adhere to Child Proof Packaging requirements, and many others to put them into compliance with regulations, such as the Position Prevention Act of 1970.

    Keep in mind that this information is meant to be a general guide. It does not identify all of the regulations, the exact wording of the regulations, and how users can adhere to the regulations. Those subject to the regulations should read through them and understand them on their own.

  • Are CBD Oil Purchases Tax Deductible? How to Categorize Buying Cannabidiol Products

    Are CBD Oil Purchases Tax Deductible? How to Categorize Buying Cannabidiol Products

    With tax season just around the corner, it’s only smart for individuals to start wondering about possible tax deductible expenses. This is even more so for people who buy and use a lot of CBD oil. If you’re wondering if buying CBD oils can be tax deductible, the short answer is it yes, IF it was prescribed by a physician.

    If you’re in doubt and need more clarification, we would suggest talking to a tax advisor before filing those taxes and adding the CBD oil purchases to your tax returns.

    What the IRS Says About Medical Expense Related Deductibles

    According to the IRS, tax payers are allowed to apply their tax deductibles to medical related expenses exceeding 7.5 percent of their adjusted gross income (AGI).

    So, if for instance, your adjusted gross income is around $40,000, you can only deduct medical expenses exceeding 7.5 percent of $40,000 ($3000). And if it’s $60,000, that’ll come to $4,500. Anything less may not be subject to tax deductions.

    To claim this, you’ll have to use the Itemized Deductions section (Schedule A) in Form 1040. Therefore, you’ll need to determine if your medical and CBD oil expenses are significant enough to fill this part of the form while filing your taxes.

    Anything Specific About CBD Oils in the IRS Rules?

    Well, that depends on whether it’s considered a medical expense or not. The IRS currently defines medical expenses as

    “the costs of diagnosis, cure, mitigation, treatment, or prevention of disease, and for the purpose of affecting any part or function of the body.”

    The organization’s document called Publication 502, specifically provides a list of medical expenses that qualify for tax deductions and those that don’t. You’ll need to check the document to ascertain this.

    But, based on our research, there’s nothing specific about CBD oil’s tax deductible properties –the document hasn’t been updated for that. The good news is that there’s information regarding nutritional supplements and marijuana products.

    In the case of CBD oil and marijuana, the Publication 502 document’s “Controlled Substances” section contains information about the plant.

    More specifically, it states that taxpayers cannot include medical marijuana-related expenses as they are not considered actual medical expenses. This is because, under federal law, marijuana is an illegal substance… according to the current documents.

    However, the section on Nutritional supplements clearly states that you

    “can’t include in medical expenses the cost of nutritional supplements, vitamins, herbal supplements, “natural medicines”, etc., unless they are recommended by a medical practitioner as treatment for a specific medical condition diagnosed by a physician.”

    What Does this Mean for CBD Oil?

    Does this mean that CBD oils can qualify as tax-deductible items if they are categorized as medically prescribed nutritional supplements category instead of marijuana? The answer is it might be possible.

    The reality is that marijuana and its many products are currently “uncharted waters” right now. The IRS hasn’t updated their laws to include the fact that cannabis, hemp, marijuana and their many products are no long illegal, thanks to the recently signed 2018 Farm Bill.

    Going by this new law, all marijuana related products are no longer under the controlled substances category. As a result, they might be qualified as “natural medicine” or nutritional supplements. But, until that is updated, this might still be an issue.

    Once done though, it just might be possible for CBD oils to be tax deductible if they are prescribed as nutritional supplements to aid the improvement of specific health condition, by your physician.

    This goes without saying that if you don’t have prescriptions for the CBD oils from your doctor, those expenses may not qualify for tax deductibility. However, you should talk to your tax advisor as they would be in the best position to give you proper tax advice.

    Please note that all the aforementioned are only applicable in the US. If you live in Canada and have been wondering it CBD oils are tax deductible in Canada, the short answer is a definite yes.

    All you need while filing your taxes with the Canada Revenue Agency (CRA), is evidence of purchase in the form of receipts from licensed and recognized dispensaries in the country.

  • President Donald Trump’s Surgeon General “Mostly Good” on Cannabis Legalization

    President Donald Trump’s Surgeon General “Mostly Good” on Cannabis Legalization

    Jerome Adams, the current surgeon general, has recognized that there is an ongoing opiate crisis that is impacting the nation and that it is one of the foremost challenges that the country is facing. Interestingly enough, his time as the surgeon general is marked by a transition to another type of substance – medical marijuana. The big question that arises is whether drug policy reform may continue and whether it can displace the current epidemic.

    A few months ago, Adams stated to an audience in Boston that their marijuana, which is classified as highly dangerous, addictive, and that has no known medical benefits, should be reexamined. There is no research to support the assertions concerning marijuana and it may be time to move forward. However, he then clarified and stated that he does not favor legalization or rescheduling, but he is looking for “evidence-based findings.”

    January 2019 featured “National Drug and Alcohol Facts Week.” During the pertinent week, Adams tweeted about marijuana and other medical professionals had called him out on it. In this tweet, he stated,

    “No child should ever use #marijuana. It is not safe for the developing brain and it affects learning and memory.”

    He then changed the tweet to

    “No child should use #marijuana/products non medically.”

    This seems to be in-tune with the FDA’s most recent move on marijuana, which was releasing a marijuana-derived pharmaceutical drug for a very specific purpose – which is to treat a certain type of epilepsy in children.

    It will be interesting to see what happens going forward and how Adam’s stance may change and evolve with the administration. Of course, because his office is a political one, there may be limits to what can be said and done.